Valsalva视网膜病变的玻璃体手术治疗

目的:探讨玻璃体切除联合内界膜剥除术对Valsalva视网膜病变的疗效与安全性。方法:对因Valsalva视网膜病变接受玻璃体手术治疗的6例7眼的临床资料进行回顾分析。所有患眼均有不同程度的黄斑内界膜下积血,3眼伴少量玻璃体积血,均以玻璃体切除联合内界膜剥除术治疗。结果:患眼视力由术前的指数或手动提高至术后第1d的0.1~0.5,并在术后1mo内继续提高,术后3,6mo;1a随诊时仍维持稳定。随访期内未观察到严重并发症。结论:玻璃体切除联合内界膜剥除术是安全、有效的治疗严重Valsalva视网膜病变的方法。

Vitrectomy with internal limiting membrane peeling for Valsalva retinopathy

AIM: To evaluate the efficacy and safety of vitrectomy with internal limiting membrane (ILM) peeling as a treatment for Valsalva retinopathy.·METHODS: Six cases (7 eyes) with Valsalva retino-pathy were treated by vitrectomy surgery and their clinical documents were retrospectively analyzed. All eyes presented premacular sub-ILM hemorrhage, in which 3 eyes were with minor vitreous hemorrhage. Treatment was standard vitrectomy with ILM-peeling. ·RESULTS: Vision was improved from finger-counting or hand-motion preoperatively to 0.1-0.5 in all eyes at the first day after operation, increased gradually within 1 month and maintained stable at 3, 6 months and 1 year during the following up. There were no serious complications. ·CONCLUSION: Vitrectomy with ILM-peeling is a safe and effective alternative to conservative treatment or YAG laser membranotomy for treating selected cases of Valsalva retinopathy.